These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16792485)

  • 1. Getting medicine to millions: New strategies for mass distribution.
    Lien O; Maldin B; Franco C; Gronvall GK
    Biosecur Bioterror; 2006; 4(2):176-82. PubMed ID: 16792485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Business and public health collaboration for emergency preparedness in Georgia: a case study.
    Buehler JW; Whitney EA; Berkelman RL
    BMC Public Health; 2006 Nov; 6():285. PubMed ID: 17116256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics and public health emergencies: rationing vaccines.
    Wynia MK
    Am J Bioeth; 2006; 6(6):4-7. PubMed ID: 17085394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency response vaccines--a challenge for the public sector and the vaccine industry.
    Milstien J; Lambert S
    Vaccine; 2002 Nov; 21(1-2):146-54. PubMed ID: 12443673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioterrorism: notes for an agenda in case of the unexpected].
    Ponce de León-Rosales S; Lazcano-Ponce E; Rangel-Frausto MS; Sosa-Lozano LA; Huerta-Jiménez MA
    Salud Publica Mex; 2001; 43(6):589-603. PubMed ID: 11816236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing the cities readiness initiative: lessons learned from Boston.
    Koh HK; Elqura LJ; Judge CM; Jacob JP; Williams AE; Crowther MS; Serino RA; Auerbach JM
    Disaster Med Public Health Prep; 2008 Mar; 2(1):40-9. PubMed ID: 18388657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortages of antibiotics, antivirals, and vaccines threaten the public health.
    Sparling PF
    Clin Infect Dis; 2001 Nov; 33(9):1502-3. PubMed ID: 11588696
    [No Abstract]   [Full Text] [Related]  

  • 8. Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.
    Schmitt B; Dobrez D; Parada JP; Kyriacou DN; Golub RM; Sharma R; Bennett C
    Arch Intern Med; 2007 Apr; 167(7):655-62. PubMed ID: 17420423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of public health interventions for Anthrax: a report to the secretary's council on Public Health Preparedness.
    Wein LM; Craft DL;
    Biosecur Bioterror; 2005; 3(4):348-56. PubMed ID: 16366844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and medicines for the world's poorest. Public-private partnerships seem to be essential.
    Smith R
    BMJ; 2000 Apr; 320(7240):952-3. PubMed ID: 10753128
    [No Abstract]   [Full Text] [Related]  

  • 11. Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys.
    Poyer S; Shewchuk T; Tougher S; Ye Y; ; Mann AG; Willey BA; Thomson R; Amuasi JH; Ren R; Wamukoya M; Taylor M; Nguah SB; Mberu B; Kalolella A; Juma E; Festo C; Johanes B; Diap G; Bruxvoort K; Ansong D; Hanson K; Arnold F; Goodman C
    Trop Med Int Health; 2015 Jun; 20(6):744-56. PubMed ID: 25728761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Business Models, Vaccination Services, and Public Health Relationships of Retail Clinics: A Qualitative Study.
    Arthur BC; Fisher AK; Shoemaker SJ; Pozniak A; Stokley S
    J Healthc Manag; 2015; 60(6):429-40. PubMed ID: 26720987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency medical services in Islamabad, Pakistan: a public-private partnership.
    Ali M; Miyoshi C; Ushijima H
    Public Health; 2006 Jan; 120(1):50-7. PubMed ID: 16198384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State preparedness for bioterrorism and public health emergencies.
    Garfield R
    Issue Brief (Commonw Fund); 2005 Jul; (829):1-12. PubMed ID: 16189904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the front lines: family physicians' preparedness for bioterrorism.
    Chen FM; Hickner J; Fink KS; Galliher JM; Burstin H
    J Fam Pract; 2002 Sep; 51(9):745-50. PubMed ID: 12366891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.
    Goodman C; Kachur SP; Abdulla S; Mwageni E; Nyoni J; Schellenberg JA; Mills A; Bloland P
    Trop Med Int Health; 2004 Jun; 9(6):655-63. PubMed ID: 15189455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of emerging manufacturers in access to innovative vaccines of public health importance.
    Milstien JB; Kaddar M
    Vaccine; 2010 Feb; 28(9):2115-21. PubMed ID: 20044054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Law, liability, and public health emergencies.
    Hoffman S; Goodman RA; Stier DD
    Disaster Med Public Health Prep; 2009 Jun; 3(2):117-25. PubMed ID: 19092672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bioterrorism exercise to real-life public health crisis: lessons for emergency hotline operations.
    Uscher-Pines L; Bookbinder SH; Miro S; Burke T
    J Public Health Manag Pract; 2007; 13(1):16-22. PubMed ID: 17149095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The strategic plan for preparedness and response to bioterrorism in Korea].
    Hwang HS
    J Prev Med Public Health; 2008 Jul; 41(4):209-13. PubMed ID: 18664725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.